Biological [bmod]
Hormone replacement therapy [topp]
Oestradiol level [lbpr]
Objective [inpr]
Tissues [tisu]
Various [irda]
body [humn]
Sensitivities [fndg]
Estradiol [horm, phsu, strd]
Very [qlco]
Difficult [qlco]
Measure [qnco]
Serum oestradiol level [lbpr]
Women [popg]
Receive [qlco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Mixture [sbst]
Estrogens [horm, phsu, strd]
Present [qnco]
Study [mnob]
Measured [qlco]
Estradiol [horm, phsu, strd]
postmenopausal [tmco]
Women [popg]
Hormone replacement therapy [topp]
Clarified [acty]
Relationships [qlco]
Serum oestradiol level [lbpr]
effects [qlco]
Hormone replacement therapy [topp]
Index [inpr]
Bone Mineral Density [clna]
Gonadotrophin [aapp, horm, phsu]
Lipid Metabolism [moft]
unscheduled [idcn]
Bleeding [patf]
Clinical Endpoint [clna]
Methods [inpr]
Eight [qnco]
postmenopausal [tmco]
Women [popg]
Aged [orga]
Suffering [mobd]
vasomotor symptom [sosy]
Hot flush [sosy]
Atrophy [patf]
Vagina [bpoc]
Assigned [ftcn]
Group [idcn]
Group [idcn]
Patients [podg]
Received [qlco]
Administration, Oral [topp]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
cee [orch]
Premarin [horm, phsu, strd]
R- [spco]
2 5 [qnco]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Provera [phsu, strd]
R- [spco]
upjohn [hcro]
Group [idcn]
Patients [podg]
Received [qlco]
Administration, Oral [topp]
mg% [qnco]
cee [orch]
2 5 [qnco]
mg% [qnco]
Every day [tmco]
Subject [grup]
Reclassified [qlco]
Group [idcn]
Serum estradiol level [lbpr]
months [tmco]
treatment [ftcn]
Low estradiol [fndg]
Group [idcn]
pg/mL [qnco]
N NOS [aapp, imft]
Middle [spco]
Estradiol [horm, phsu, strd]
Group [idcn]
Equal [qlco]
pg/mL [qnco]
N NOS [aapp, imft]
high estradiol [fndg]
Group [idcn]
Equal [qlco]
pg/mL [qnco]
N NOS [aapp, imft]
Examined [fndg]
Relationships [qlco]
Serum estradiol level [lbpr]
effects [qlco]
Estradiol [horm, phsu, strd]
Index [inpr]
Bone Mineral Density [clna]
Gonadotrophin level [lbtr]
Lipid [lipd]
Profile [lbpr]
unscheduled [idcn]
Bleeding [patf]
Group [idcn]
Obtained [ftcn]
newly [idcn]
Chromatography, High Performance Liquid [lbpr]
Radioimmunoassay [lbpr]
System [ftcn]
effects [qlco]
Tissue [tisu]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Oral [spco]
cee [orch]
Oestradiol level [lbpr]
effects [qlco]
Hormone replacement therapy [topp]
Bone Mineral Density [clna]
Gonadotrophin level [lbtr]
Lipid [lipd]
Profile [lbpr]
Dependent [qlco]
Serum oestradiol level [lbpr]
Hormone replacement therapy [topp]
Index [inpr]
Serum estradiol level [lbpr]
Very low [fndg]
Concentration [menp]
Estradiol [horm, phsu, strd]
pg/mL [qnco]
Sufficient [qlco]
suppress [ftcn]
fsh levels [lbtr]
relieve [ftcn]
vasomotor symptom [sosy]
Minimum [qlco]
Concentration [menp]
Estradiol [horm, phsu, strd]
Required [ftcn]
Bone Mineral Density [clna]
pg/mL [qnco]
Hand [bpoc]
Estradiol [horm, phsu, strd]
Required [ftcn]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Apolipoprotein B [aapp, bacs]
pg/mL [qnco]
Required [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Apolipoprotein A-I [aapp, bacs]
pg/mL [qnco]
unscheduled [idcn]
Bleeding [patf]
Low estradiol [fndg]
Group [idcn]
Oestradiol level [lbpr]
Group [idcn]
Suggest [idcn]
Clinical Endpoint [clna]
Thresholds, Differential [qnco]
Response [orga]
reflect [menp]
Tissue sensitivity [sosy]
Oestradiol level [lbpr]
Hormone replacement therapy [topp]
Copyright [inpr]
basel [hcro]
